Bird & Bird advised Nexstim on cooperation and investment agreements with Brainlab

International law firm Bird & Bird has successfully advised Nexstim Plc, a Finnish, globally operating growth-oriented medical technology company, on its cooperation agreement and investment agreement with Brainlab AG, a leading German developer of advanced medical technology solutions.

The cooperation agreement aims at the advancement of non-invasive brain mapping technologies, as well as the distribution of certain Nexstim products by Brainlab in the segment. 

In connection with the cooperation agreement, Brainlab and Nexstim have also agreed on a maximum of EUR 5,095,000 equity investment into Nexstim by Brainlab. 

Bird & Bird’s advisory team, consisting of partners Maria Carlsson, Laura Huomo, and Iina-Mari Supperi, along with Counsel Vuokko Rajamäki and associates Juliana Kliesch, Marla Melin and Rondy Stenman, provided comprehensive legal support for both the cooperation and investment agreements.

News & Deals

More News & Deals
Deal Successful Defence of Heineken in Landmark HoReCa Foreclosure Case

Feb 18 2026

Read More
Deal Bird & Bird advises Kainova Therapeutics on its Series B funding round of $CAD 32 million

Feb 16 2026

Read More
Deal Bird & Bird advises WSC Sports on its acquisition of Partnerbrite

Feb 12 2026

Read More
News Bird & Bird boosts London Tech & Comms team with new partner Gordon Moir

Feb 12 2026

Read More
News Bird & Bird Advises International Finance Corporation (IFC) on Investment in Mozark

Feb 11 2026

Read More
News Bird & Bird, OXYGY, and EU Commission unveil final best practices report for the European Blockchain Sandbox

Feb 11 2026

Read More